A case of multiple sclerosis associated with rheumatoid arthritis and positive anticardiolipin antibodies

Annals of the Rheumatic Diseases

Volumn 62, Issue 4, 2003, Pages 376-

  Mpofu, S ^a   Moots, R J ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACUTE PHASE PROTEIN; BACLOFEN; CARDIOLIPIN ANTIBODY; DANTROLENE; FOLIC ACID; IBUPROFEN; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; EVOKED VISUAL RESPONSE; HUMAN; JOINT EXAMINATION; LOW DRUG DOSE; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PHYSICAL EXAMINATION; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPASTICITY; SYNOVITIS; TREATMENT OUTCOME;

ANTIBODIES, ANTICARDIOLIPIN; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0037379338     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.4.376     Document Type: Article

References (7)

1. Kollias G, Douni E, Kassiotis G, Kontoyiannis D. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis 1999;58(suppl 1):132-9.
2. Adorini L, Bonneville M, Kollias G. Pathogenic and protective T-cell responses in autoimmune diseases. Res Immunol 1998;149:873-5.
3. Kassiotis G, Bauer J, Akassoglou K, Lassmann H, Kollias G, Probert L. A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. Eur J Immunol 1999;29:912-17.
4. Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumour necrosis factor alpha antagonism: by what mechanisms could tumour necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 2001;44:1977-83.
5. Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, et al. Demyelination occurring during anti-tumour necrosis factor alpha therapy for inflammatory arthritides Arthritis Rheum 2001;44:2862-9.
6. de Andres C, Guillem A, Rodriguez-Mahou M, Lopez Longo FJ. Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients. Acta Neurol Scand 2001;104:83-7.
7. Roussel V, Yi F, Jauberteau MO, Couderq C, Lacombe C, Michelet V, et al. Prevalence and clinical significance of anti-phospholipid. J Autoimmun 2000;14:259-65.